Daclatasvir dihydrochloride
Product Specifications
CAS Number
1009119-65-6
Target
HCV Protease
Related Pathways
Microbiology/Virology, Proteases/Proteasome
Purity
0.9984
Bioactivity
Daclatasvir dihydrochloride (BMS-790052 dihydrochloride) is an orally available antiviral agent that inhibits the NS5A region of the hepatitis C virus (HCV) and is used in combination with other oral antivirals to treat chronic hepatitis C. Elevations in serum enzyme levels during daclatasvir therapy are uncommon, and it has not been convincingly implicated in cases of clinically apparent liver injury with jaundice.
Smiles
Cl.Cl.COC(=O)N[C@@H](C(C)C)C(=O)N1CCC[C@H]1c1ncc([nH]1)-c1ccc(cc1)-c1ccc(cc1)-c1cnc([nH]1)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)OC)C(C)C
Molecular Formula
C40H52Cl2N8O6
Molecular Weight
811.8
Shipping Conditions
Ice Packs
Storage Temperature
-20°C
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
PKSH033327-01 10 µg
Recombinant Human ALDH3A1 Protein (Human Cells, His Tag)
Sign In for Pricing
View Details PKSH033327-02 50 µg
Recombinant Human ALDH3A1 Protein (Human Cells, His Tag)
Sign In for Pricing
View Details 
BNC881775-500 1x 500 µL
CFTR (Cystic Fibrosis Transmembrane Conductance Regulator) (CFTR/1775R), CF488A conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC680031-500 1x 500 µL
Mucin 5AC (MUC5AC) (45M1), CF568 conjugate, 0.1mg/mL
Sign In for Pricing
View Details